mally the particles are rapidly removed from the circulation. [8] [9] [10] [11] Since the systemic capillary wall is relatively impermeable to lipids,12-14 and particularly to the larger chylomicra, 15 16 various pathways for the transfer of alimentary neutral fat from the blood to the tissues must be considered other than direct diffusion through the capillary wall to the extravascular fluid. Three possible mechanisms have been proposed: triglyceride lipolysis by a heparin-activated enzyme (lipoprotein lipase) taking place in the plasma or at the capillary endothelial wall, phagoeytosis of chylomicra by reticuloendothelial cells, and finally direct passage of chylomicra as such from the plasma into the liver. This latter possibility is supported by observations of fat within the liver parenchymal cells shortly after the injection of chyle in experimental animals,17' 18 and by the demonstration that the endothelium of the hepatic sinusoids is more permeable to chylomicra than is the systemic capillary endothelium.18 It therefore seemed pertinent to investigate liver function in patients with elevated levels of systematic study of this question although liver function tests have undoubtedly been performed in many such patients.
Methods
The individuals selected for this study were private patients in whom elevated levels of serum cholesterol and low-density lipoproteins had been found on at least 2 separate occasions. In a few cases only one of the lipids was abnormal. Serum cholesterol was measured by one of the standard methods,19 and the lipoproteins were determined by ultracentrifugal analysis.* Although the "normal" values for these lipoproteins have not been defined, the range of means for standard Sf 0-12 lipoproteins in men aged 30 to 69 is 367 to 407 mg. per cent, and in women is 301 to 392 mg. per cent. The means for the Sf 12 to 400 class of lipoproteins in men is 217 to 235 mg. per cent, and in women 142 to 274 mg. per cent.21' The liver function tests used were the thymol turbidity, cephalin flocculation, sulfobromophthalein excretion, cholesterol esterifieation and, although not shown in the table, the urine urobilinogen excretion, all performed according to standard procedures. Forty-two patients were studied but cholesterol esters and urine urobilinogen were not measured in all cases.
Results
The findings are shown in table 1 
Discussion
The liver plays a fundamental role in various aspects of fat metabolism, and liver dysfunction may profoundly affect serum lipid values. 22 The data obtained in the present study, however, imply that the liver is not responsible for impairment in the removal of alimentary fat fromn the bloodstream. Chronically elevated blood lipids, as found in the 42 patients of this study, are usually associated with an impaired clearance of alimentary lipemia.1-7 It may be argued, however, that none of the tests used directly assessed the ability of the liver parenehymal cells to remove chylomicra. It is therefore pertinent to evaluate other studies of this subject.
Although the systemic capillary wall bars the passage of large lipid-containing molecules from the blood to the tissues,12-16 the hepatic sinusoids are more freely permeable to chylomicra,'17 18 at least in experimental animals. Thus hepatic tissue apparently does come into direct contact with triglycerideladen particles from the blood plasma. It does not necessarily follow that the bulk of this material is removed by the liver; it simply may be altered, perhaps coniverted to lipoproteins, so as to be soluble in blood. (It has been pointed out23 that "hepatic lymph is limpid, resembling serum in composition. If, therefore, the liver picks up particulate lipids from the blood it converts them to lipoproteins.") There is also direct evidence on this question. Counts of chylomicra in the hepatic lymph of cats, both fasting and during digestion, were slightly less than counts in plasma,18 indicating little retention of chylomicra in the liver. Furthermore, liver lymph in normal animals absorbing fat was always clear despite its high chylomicron content, suggesting increased solubility of these particles. In any event, since the liver does not contain a true lipase,24' 25 and since it inactivates lipoprotein lipase,26 breakdown of triglyceride by this organ seems unlikely.
Recently the question of the direct uptake of chylomicra by the liver has been approached by 2 groups of investigators using the isolated rat liver. In one study27 the up-take of radioactivity by the liver was determined following the perfusion via the portal vein of rat chyle labeled radioactively in the fatty acid moiety. Fifty-four to 60 per cent of the label was taken up by the liver in 3 hours. When the perfusate also contained post-heparin lipoprotein lipase, 75 to 93 per cent of the labeled material was removed, whereas 45 to 55 per cent was removed wheni the perfusate contained Triton WR 1339, an inhibitor of the lipemia-clearing factor. Liver sections made after 3 hours of perfusion revealed fat globules in the parenehymal cells at the cell margin adjacent to the hepatic sinusoids and only a few fat droplets in Kupffer cells. The authors stated that there was no evidence that Kupffer cells have an essential part in the process of chylomieron uptake, but that their results showed that the liver parenchymal cells can take up chyle fat directly and that an intravascular clearing reaction is not an essential step in the process. Other considerations, however, cast serious doubts upon these interpretations. The flow of lipids from the liver was not measured; therefore the uptake of radioactively labeled fatty acid by the liver simply may indicate exchange between the triglycerides or fatty acid moiety of the chylomicra and similar constituents of the liver cell rather than uptake of chylomicra. The fatty acids of chylomicra have recently been shown to exchange (without preliminary hydrolysis) at the same rate as cholesterol.28 Furthermore, although Triton markedly slowed the removal of chylomicra from the blood in intact rats,10 it had no effect on the uptake of fat by the liver in vitro. This ineonsistency was noted but not explained by the authors. It would seem that the in vitro and in vivo experiments were not directly comparable. This suggestion is reenforeed by the frequent finding of dilated sinusoids and edema and distention of the portal tracts at the end of the perfusioni period.
Another study28 has afforded evidence that the liver has only a minor role, if any, in chylomicron removal. When C14-labeled albumin-palmitic acid complex was perfused Circulation, Volume XXII, August 1990 through the isolated rat liver, 34 to 43 per cent of the C14 was removed in a single passage through the liver, whereas only 4 to 5 per cent was removed when chylomicra-contaiming palmitate-1-C14 was perfused. Again, even the latter figure does not prove that chylomicra are removed, since it may simply represent exchange of the fatty acid moiety. Furthermore, since heparin was used during the operative procedure, the resultant lipoprotein lipase activity may not have been completely removed by the preliminary 1minute wash of the liver prior to the chylomicron perfusion. This suggestion is supported by the slower disappearance of cholesterol-4-C14 from perfused chylomicra than of palmitate-1-C14. This finding is not indicative of liver removal of whole chylomicra but rather of preliminary lipolysis and take-up of the released fatty acid. Thus, it appears most likely that the role of the liver parenchyma is not the removal and lipolysis of chylomicra but their conversion to lipoproteins and subsequent return to the circulation. In fact, an increased rate of clearing of lipemia has been found after the injection of an oil emulsion (Lipomul) intravenously in patients with advanced hepatic damage,29 an observation inconsistent with the concept of a major primary role of the liver in fat clearing.
We may now consider the evidence that the reticuloendothelial system functions in the clearing of alimentary fat from the blood in man. Much work has been done on this subject in experimental animals, and the results are somewhat confusing. Blockade of the reticuloendothelial system in rats, rabbits, and dogs fed fat and cholesterol resulted in more marked chylomicronemia and hypercholesteremia than in control animals.30' 31 A decreased rate of clearance of cholesterol from the blood was found when reticuloendothelial cells were partially blocked by carbon.32 Furthermore labeled cholesterol was found in hepatic Kupifer and parenchymal cells after animals were fed labeled cholesterol and olive oil.33 However, the fast exchange of the free cholesterol of chylomicra with that of the Circulation, Volume XXII, August 1960 high-density lipoproteins,34 and the rapid equilibration of free cholesterol among plasma, liver, and blood cells35 short circuited the actual removal of chylomicra, and some exogenous cholesterol was quickly mixed with the endogenous pool. This makes it most difficult to evaluate studies33 of the immediate fate of newly absorbed labeled cholesterol. Furthermore, other workers have not found that reticuloendothelial-system blockade increased plasma cholesterol levels. 36 Recently, with a magnetic technic for the separation of hepatic parenchymal and Kupffer cells, the phospholipid and neutral fat content of the 2 types of cells was found to be about the same in fasted dogs and rats but the cholesterol content of the Kupffer cells was 2 to 3 times that of the parenchymal cells.37 These data suggest a specialized role of the reticuloendothelial cells in cholesterol metabolism, but not necessarily a specific role of these cells in the uptake of exogenously administered cholesterol. With the same technic in fat-fed dogs data were obtained that "did not support the concept of a major role of the reticulo-endothelial system in the removal of chylomicra. " 38 Direct evidence against chylomicron phagocytosis by reticuloendothelial cells was found after liver perfusion in vitro,27 and after infusions of chyle in intact rats and dogs. In these animals chyle fat never appeared in the Kupffer cells although it did after the injection of oil emulsions.17 The latter apparently are treated as a foreign substance and cannot be equated with chyle fat. Even with oil emulsions, however, when the reticuloendothelial system was blocked and no fat was found in these cells, the emulsion was removed from the bloodstream at a normal rate, providing additional evidence of the minimal role played by the reticuloendothelial system in the clearance of fat particles. 39 The discussion thus far leads to the probability that neither the liver nor the reticuloendothelial system occupies the central position in the major physiologic mechanism responsible for the removal of alimentary neutral fat from the bloodstream. They are involved in this process, and their dysfunetion may affect triglyceride metabolism adversely, but the bulk of the available evidence does not suggest that such dysfunction usually accounts for hypertriglyceridemia. We may now turn to a consideration of the remaining pathway proposed for the clearing of alimentary lipemia, the enzymatic heparin lipoprotein-lipase mechanism, reviewed elsewhere.40 Briefly, following the injection of heparin in animals and man, an active factor can be demonstrated in plasma which catalyzes the lipolysis of the triglyceride component of chylomicra and of the larger lowdensity or beta lipoproteins. Albumin is essential as the carrier of the released unesterified fatty acids. This lipolytic factor has been identified, without the prior injection of heparin, in animal tissue41 and in the plasma of some human subjects. 42' 43 Some clinical observations, insufficiently emphasized heretofore, support the thesis that the heparin lipoprotein-lipase mechanism is probably the major physiologic channel for the removal of alimentary lipemia in man. No defect is known in reticuloendothelial or liver function in the majority of patients with the nephrotic syndrome or with essential hyperlipemia. These individuals, however, do have an interference, of one type or another, with the heparin lipolytic mechanism, and they have a persistent marked elevation of plasma neutral fats and a delayed fat clearance from the blood. 44 In nephrosis there is a lack of circulating albumin, which functions as a carrier molecule for unesterified fatty acids. Studies by various investigators have shown that in this disease, in man and animals, the only demonstrable defect responsible for the increased serum lipids is a lack of the acceptor protein, albumin.45-48 When plasma albumin rises, lipid levels decrease. 46 4 In many case reports of essential hyperlipemia no primary liver disturbance has been observed by liver function tests, at surgery, or at autopsy. Several types of abnormalities have been described, however, that markedly hamper the lipoprotein-lipase system. The chylomicra of 1 patient were a very poor sub-strate for this enzyme.50 In 3 siblings with the disease, very little lipoprotein-lipase activity appeared following the injection of heparin, indicating a deficiency of the tissue apoenzyme of lipoprotein lipase.5' In other patients with essential hyperlipemia an inhibitor of post-heparin lipemia-clearing activity has beendemonstrated.51 One other study afforded strong evidence of the physiologic relationship between the heparin lipemiaclearing mechanism and serum low-density lipoproteins with a high neutral fat content.
In a survey of 482 patients endogenous plasma-clearing activity was found in 112 individuals. 53 The lipoproteins were determined in 72 of the 112, and in 162 of the subjects in whom clearing activity was not present.
In the latter group the Sf 12 to 400 lipoproteins averaged 257 mg. per cent in contrast with 195 mg. per cent in the patients with clearing factor. This difference was statistically significant. These observations and many others recently summarized54 demonstrate that when the heparin lipolytic enzyme svstem is impaired, clearance of alimentary lipemia is delayed and serum triglycerides are markedly elevated. This indicates the central role of this mechanism in fat transport. Other pathways for the removal of alimentary fat from the blood undoubtedly exist but they would appear to be subsidiary, and usually are not fully compensatory unless fat intake is reduced substantially. Summary Liver function tests were performed in 42 individuals with increased levels of serum cholesterol and low-density lipoproteins. The tests were normal in 39 patients; the sulfobromophthalein excretion was impaired in 3.
These results indicate that disturbances in liver function are not usually involved in elevations of serum triglycerides. Other clinical evidence is discussed which suggests that the heparin lipoprotein-lipase lipolytic mechanism, but not the liver or reticuloendothelial system, occupies the initial role in the removal of alimentary fat from the bloodstream in man.
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Summario in Interlingua
Tests del function hepatic esseva executate in 42 subjectos con augmentate nivellos seral de cholesterol e de lipoproteina a basse densitate. Le tests esseva normal in 39 casos. In 3, le excretion de sulfobromophthaleina esseva disturbate. Iste resultato indica que dysfunction hepatic non es usualmente associate con elevate nivellos seral de triglyceridos. Es discutite altere factos que suggere que le mechanismo lipolytic de heparina, a lipase de lipoproteina, e non le hepate o le systema reticuloendothelial, joca le rolo central in le elimination de grassia alimentari ab le circulation del sanguine in humanos.
